Do the pelvic lymph nodes predict the parametrial status in cervical cancer stages IB-IIA?

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
R PuenteM T Poblete

Abstract

The aim of this study was to determine whether the pelvic lymph nodes would predict the parametrial status in patients with cervical cancer stages IB1-IIA submitted to radical surgery and pelvic lymphadenectomy. To this end, we evaluated the relationship between positive and negative pelvic lymph nodes and their parametria. Our final purpose was to use this information to recommend the tailoring of the parametrial resection according to the status of pelvic lymph nodes to decrease the morbidity related with radical paratrectomy. From January 1996 to December 2001, 107 consecutive patients with cervical cancer stages IB1 and IIA were primarily treated by radical hysterectomy type III with systematic pelvic lymphadenectomy in a prospective study. Parametria were studied in two sections: the first included the tissue adjacent to the cervix, and the second the distal 2/3. Lymph nodes were routinary processed. Twenty-two patients (20.6%) had positive pelvic nodes and 16 patients (14.9%) had parametrial involvement, mostly by direct extension. Eight patients with positive pelvic nodes (36.4%) had parametrial involvement, whereas among 85 patients with negative pelvic nodes only eight patients (9.4%) had parametrial involvement (P < 0...Continue Reading

References

Jan 1, 1996·Obstetrics and Gynecology·L A Ballard, M D Walters
Jan 1, 1996·Free Radical Research·L R MilgromN N Jogiya
Jun 1, 1996·Journal of Psychosomatic Obstetrics and Gynaecology·A Lalos, O Lalos
Feb 1, 1996·Surgical Endoscopy·S P DexterM J McMahon
Feb 18, 1998·American Journal of Obstetrics and Gynecology·W T CreasmanH D Homesley
Mar 4, 1998·Current Opinion in Obstetrics & Gynecology·J Elkas, R Farias-Eisner
Feb 27, 1999·Current Opinion in Obstetrics & Gynecology·J M Childers
Aug 31, 1999·The Proceedings of the Nutrition Society·J D Cook
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·B. HagenI. J. Jacobs
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P. ZolaP. Sismondi
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S. M. KimJ. S. Byun
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T. NakanishiK. Kuzuya
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. S. MetcalfK. R. Peel
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R. AngioliM. Penalver
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T. KawagoeT. Aoki
Jul 5, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J B TrimbosG G Kenter
Aug 25, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K NarayanA F McKenzie
Sep 29, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G. ComerciJ. M. Monaghan
Sep 29, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R. A. K. SamlalF. B. Lammes
Mar 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E. SartoriS. Pecorelli
Sep 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F. LandoniC. Mangioni

❮ Previous
Next ❯

Citations

Jun 14, 2012·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Lukas RobPetr Skapa
Jan 11, 2011·Gynecologic Oncology·John P DiazNadeem R Abu-Rustum
Mar 6, 2010·The Lancet Oncology·Lukas RobHelena Robova
Mar 6, 2007·Gynécologie, obstétrique & fertilité·S VignancourE Leblanc
Dec 12, 2012·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Jaroslav KlatOtakar Kraft
Mar 7, 2006·Gynecologic Oncology·H SteedW Faught
Jul 12, 2005·Gynecologic Oncology·Markus C Fleisch, Kenneth D Hatch
Jul 23, 2015·Journal of Gynecologic Oncology·Hiroyuki YamazakiHidenori Kato
Oct 13, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Tsuyoshi YamashitaKazuo Sengoku
Apr 23, 2019·Archives of Gynecology and Obstetrics·G F VercellinoJalid Sehouli
Nov 28, 2017·Archives of Gynecology and Obstetrics·Congcong MaPeishu Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.